Cytokine protection in multiple sclerosis

Ciliary neurotrophic factor and leukaemia inhibitory factor have protective effects in a model of multiple sclerosis.

Tudor Toma(t.toma@ic.ac.uk)
Jun 6, 2002

Multiple sclerosis (MS) is a chronic inflammatory disease involving immunological mechanisms that lead to demyelination of the central nervous system. Two papers in June Nature Medicine show that ciliary neurotrophic factor (CNTF) and leukaemia inhibitory factor (LIF) are two cytokines that have protective effects in a murine model of MS.

Ralf Linker and colleagues from Julius-Maximilians-Universität Würzburg, Austria, worked with CNTF-deficient and wild-type mice and found that CNTF is a major protective factor in demyelinating CNS disease. The vacuolar dystrophy of myelin and axonal damage was more severe and recovery was poor in CNTF-deficient mice. These effects could be prevented by treatment with an antiserum against tumor necrosis factor-α, suggesting that endogenous CNTF may counterbalance TNF-α (Nat Med 2002, 8:620-624).

In the second paper, Helmut Butzkueven and colleagues at the University of Melbourne, Australia, observed that administration of LIF could reverse the loss of oligodendrocytes normally...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?